BRIEF published on 12/19/2025 at 12:05, 8 months 6 days ago Biotest AG Announces FDA Approval of Grifols' Fesilty™ FDA Approval Biotest AG U.S. Market Grifols Fibrinogen Therapy
PRESS RELEASE published on 12/19/2025 at 12:00, 8 months 6 days ago Biotest announces US FDA approval of Grifols’ Fesilty™ (fibrinogen, human-chmt) Biotest AG announces US FDA approval of Grifols’ Fesilty™ (fibrinogen, human-chmt) for acute bleeding episodes in patients with fibrinogen deficiency Biotest AG Fibrinogen Grifols US FDA Approval Fesilty
BRIEF published on 11/13/2025 at 10:12, 9 months 12 days ago Biotest Obtains Approval for Prufibry® in Germany Clinical Trials Biotest AG German Market Prufibry® Approval Fibrinogen Deficiency
PRESS RELEASE published on 11/13/2025 at 10:07, 9 months 12 days ago Biotest obtains approval for new human fibrinogen Prufibry® in Germany Biotest AG obtains approval in Germany for new human fibrinogen Prufibry®, expanding intensive care and coagulation factor portfolio with a life-saving therapy for congenital and acquired fibrinogen deficiency Germany Biotest AG Approval Human Fibrinogen Prufibry
BRIEF published on 11/07/2025 at 15:24, 9 months 18 days ago Biotest AG Schedules Extraordinary General Meeting at Grifols' Request Grifols S.A. Extraordinary General Meeting Biotest AG Legal Form Change Partnership Limited By Shares
PRESS RELEASE published on 11/07/2025 at 15:19, 9 months 18 days ago Biotest AG: Extraordinary general meeting convened again at the request of Grifols S.A. Biotest AG convenes an extraordinary general meeting at the request of Grifols S.A. to discuss changing its legal form to a partnership limited by shares (KGaA) on 17 December 2025 Grifols S.A. Extraordinary General Meeting Biotest AG Legal Form Change Partnership Limited By Shares
BRIEF published on 10/23/2025 at 13:21, 10 months 2 days ago Biotest AG Cancels Extraordinary General Meeting Grifols S.A. Extraordinary General Meeting Legal Form Change Corporate Restructuring Biotest AG News
PRESS RELEASE published on 10/23/2025 at 13:16, 10 months 2 days ago Biotest AG: Cancellation of the extraordinary general meeting on 28 October 2025 Biotest AG cancels extraordinary general meeting scheduled for 28 October 2025 following withdrawal of convocation request by Grifols S.A Grifols S.A. Cancellation Extraordinary General Meeting Biotest AG Legal Form Change
BRIEF published on 10/09/2025 at 17:35, 10 months 16 days ago Biotest's Yimmugo® Enters the U.S. Market Biotest AG U.S. Market Yimmugo® Launch Primary Immunodeficiencies Plasma-derived Medicines
PRESS RELEASE published on 10/09/2025 at 17:30, 10 months 16 days ago Biotest’s Yimmugo® launches in the United States Biotest AG launches Yimmugo®, a polyvalent human normal immunoglobulin (IVIg) for primary immunodeficiencies in the U.S., marking a significant milestone for the company's global growth strategy Biotest AG Yimmugo U.S. Launch Primary Immunodeficiencies IVIg
Published on 08/25/2026 at 23:05, 5 hours 13 minutes ago Faraday Copper Shareholders Approve Share Issuance in Connection with the Acquisition of the San Manuel Project
Published on 08/25/2026 at 15:00, 13 hours 18 minutes ago Four Nines Gold Intersects Hydrothermal Breccia in First Three Holes at Hayden Hill
Published on 08/25/2026 at 14:30, 13 hours 48 minutes ago First Breach Completes First Flight of Drone Prototype and Advances American-Made Manufacturing Through Hellbender Agreement
Published on 08/25/2026 at 14:30, 13 hours 48 minutes ago Tintina Mines Completes Strategic Partnership Transaction, Consolidating 100% Ownership of the Dos Amigos (formerly Domeyko Sulfuros) Copper-Gold Project in Chile
Published on 08/26/2026 at 03:58, 19 minutes ago EQS-Adhoc: AUSTRIACARD HOLDINGS AG: DAI NIPPON PRINTING CO., LTD. INTENDS TO PURSUE SQUEEZE-OUT AND DELISTING
Published on 08/26/2026 at 03:15, 1 hour 2 minutes ago Binzhou Unveils 'Trade-In' Housing Models to Stabilize Real Estate Market
Published on 08/25/2026 at 22:35, 5 hours 42 minutes ago ZOOPUNK Makes Its Opening Night Live Debut at gamescom 2026
Published on 08/25/2026 at 20:35, 7 hours 42 minutes ago Michter's Named the #1 Most Admired Whiskey in the World by Drinks International in New 2026 Ranking
Published on 08/25/2026 at 17:45, 10 hours 33 minutes ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 08/25/2026 at 17:45, 10 hours 33 minutes ago Imerys-08-2026-information-share-capital-and-voting-rights-as-of-31-July-2026
Published on 08/25/2026 at 08:30, 19 hours 48 minutes ago Eiffage wins several contracts worth a total of €132 million in the healthcare sector
Published on 08/24/2026 at 18:00, 1 day 10 hours ago Outstanding shares and voting rights statement at 31 July 2026
Published on 08/24/2026 at 17:59, 1 day 10 hours ago Saint-Gobain strengthens its positioning in construction chemicals and light construction in Latin America
